Servier’s Post

🔥 Drug Launches are About to Get a Whole Lot Smarter! 💡 Ever felt overwhelmed by the sheer volume of data and insights needed for a successful drug launch? 💊 We get it. The stakes are high, and the pressure is immense. But what if I told you there’s a game-changing solution that could transform this complex process? Imagine harnessing the power of generative AI to streamline your drug launches, delivering the right information exactly when you need it. No more guesswork. Just pure, actionable insights. 👉 Ready for the future of pharmaceutical excellence? Discover how generative AI is revolutionizing drug launches right here: [Power Launch Excellence with Generative AI](https://lnkd.in/gdE2xBSN) Don't get left behind. 🚀 #PharmaInnovation #GenerativeAI #DrugLaunchSuccess

It was great to attend the insightful VWV PING Conference 2024 on AI in Pharma yesterday at Knebworth House and Barns. For those who missed it, the event explored whether AI poses a threat or opportunity for the pharmaceutical industry. Some standout talks for our Founder, Lisa were: - Dr. Sola Adeleke (Curenetics Founder and CEO) discussed using AI to predict patient treatment responses and allocate personalised medicine pathways more accurately. - Dr. Rav Seeruthun (health-equity.ai CEO) explored how AI could help solve healthcare disparities. - James Turnbull (Camino Communications Founder and co-member of The Health House) discussed leveraging generative AI for competitive advantage in pharma marketing and extracting unique insights from market/product data. While there are risks like data bias to address, the opportunities for ethical AI to improve healthcare and pharmaceutical operations seem immense based on the conversations. What are your thoughts on AI in pharma? Threat or opportunity? Let us know in the comments ⬇

𝐈𝐀 & 𝐇𝐞𝐚𝐥𝐭𝐡 💉💊 The last weekend I had the opportunity to visit the AI Exhibition, organized by the Centre de Cultura Contemporània de Barcelona (CCCB) As mentioned by the World Economic Forum, in its article on how IA could boost the pharmaceutical industry, Generative AI has the capacity to increase the chances of success in therapeutic programs by helping to choose the right disease target and generate a highly optimized molecule with the desired properties. 🔎 Finding new innovative therapeutic alternatives with the help of AI, without doubt, will help to improve research times and reduce the waste of resources, always looking for a better benefit for the patient. Reference: https://lnkd.in/dWmKaMcZ #IAhealth #IA #healthcare

Let's see AI in action and its groundbreaking applications across industries! 👀 This week, our spotlight is on the pharmaceutical sector, where AI is truly shaking things up. Take Insilico Medicine, for example—they started by using AI to identify potential drug candidates and optimize their molecular structures, all while drastically cutting down on time and cost. Even in the face of challenges like high costs and complex data, they’ve managed to accelerate the development of life-saving treatments, achieving in months what usually takes years. And now, they’ve reached the exciting milestone of launching the first fully AI-designed drug into clinical trials! But that's not the only game-changer in town. Companies like Pfizer and Tempus AI are making waves with their innovative use of AI, pushing the boundaries of what’s possible in pharma. Curious about these incredible AI stories? Learn more about their use cases by checking out our blog post: https://hubs.la/Q02PDRyP0 #AIUseCaseofTheWeek #AI #pharma

🔍 Curious about the latest trends in #AI within commercial pharma? Dive into our new report revealing the current state of AI adoption, challenges, and opportunities in the industry. Discover key insights and industry benchmarks that can shape your strategies and decisions. Read the full report>> https://lnkd.in/dkahf63j #StateOfTheIndustry #Pharma #FutureofAI #IndustryInsights

Artificial intelligence (AI) is revolutionizing the pharmaceutical industry by significantly enhancing various stages of drug development. The ability to reduce drug development timelines by up to two years demonstrates AI's potential to accelerate time-to-market, allowing faster delivery of innovative therapies to patients. Generative AI, recognized for its ability to enhance efficiencies by 92%, is reshaping research methodologies and streamlining processes. Additionally, AI's capability to facilitate decision-making by 65% is critical in optimizing designs and outcomes. The financial implications are equally impressive, with an estimated $26 billion in savings through the acceleration of drug development timelines. Embracing AI in pharma not only promises enhanced operational efficiencies but also substantial economic benefits. Statistics credit: ideas2it.com Reference Article: bit.ly/4djj1qQ #ai #artificialintelligence #pharmaceuticaldevelopment #drugdiscovery #industrystats

Drug Development using  AI – panel on 4-19-2024 https://lnkd.in/dAHs6J-Y Integration of Diverse Data Sets: The integration of vast and complex datasets is crucial. This approach is being used to understand risk predictions for diseases better, and to design clinical trials more effectively. Challenges in Biologics and Small Molecule Development: There is a significant focus on creating transformative therapies, especially in replacing biologics with small molecules, which are accessible to a smaller fraction of patients but can be tailored for wider application thanks to AI. Future of AI in Health: The discussion points towards the potential of AI not only in early stages of drug development but also across the whole spectrum including clinical trial stratification and patient diagnosis. AI is expected to bring about fundamental changes in how therapies are developed and administered. Economic and Efficiency Gains: AI could potentially increase the efficiency and reduce the costs associated with drug development, particularly in clinical trials, thus allowing greater investment in other areas. Precision Medicine: There's a strong emphasis on precision medicine—developing therapies that are precisely matched to specific patient genetics and disease mechanisms, which AI is particularly suited to enhance. #artificialintelligence #generativeai #precisionmedicine #drugdevelopment #biochemistry

The #biopharmaceutical industry is at a pivotal juncture. Companies using intelligent technologies like AI and machine learning to create life-changing treatments are positioning themselves as pioneers - Accenture. Reinventing the R&D organisation requires prioritising two overarching tasks: 🔰 Identifying reinvention opportunities - Using AI for discovery - Developing and manufacturing new types of treatments - Optimising clinical trials - Dynamic portfolio management 🔰 Addressing the imperatives that power reinvention - A secure, AI-ready digital core - Talent and leadership - A culture of continuous reinvention #biopharma #ai #artificialintelligence #generativeai #drugdiscovery #researchanddevelopment #digitaldisruption #digitaltransformation Paidi O Reilly Prof. Dr. Ingrid Vasiliu-Feltes Martin Moeller Aaron Lax Richard Turrin Sally Eaves Imtiaz Adam Irene Lyakovetsky🎧🎙 Dinis Guarda Antonio Grasso Dr. Martha Boeckenfeld Ian Jones Nicolas Babin Mike Flache Olivier Gomez (𝐎𝐆) Giuliano Liguori Dr. Marcell Vollmer Birgul COTELLI, Ph. D. Enrico Molinari Efi Pylarinou Prof. Dr.Dominique J.E. Delporte - Vermeiren, PhD., Hon.Dr. Franco Ronconi Dr. Khulood Almani🇸🇦 د.خلود المانع Olivier Kenji Mathurin Zvonimir Filjak Eveline Ruehlin Nafis Alam Patrick Maroney Orlando Francisco F. Reis Dr. Debashis Dutta Bob Shami Victor Yaromin Neville Gaunt 💡⚡️ Olivier LABORDE Per Brogaard Berggren Hope Frank Jean-Baptiste Lefevre Lionel Costes Anthony Rochand

The pharmaceutical landscape is undergoing a transformative shift thanks to the integration of generative AI in drug discovery. This cutting-edge technology is not just accelerating the identification of new compounds but is also reshaping the entire drug development pipeline, from research to clinical trials. Generative AI's ability to analyze vast datasets and predict molecular behavior is cutting drug discovery timelines significantly, potentially halving the process. This leap forward could translate into more rapid advancements in medicine, addressing urgent needs and saving lives. As we embrace this era of innovation, it's crucial for industry leaders to navigate the strategic and operational challenges that come with adopting such technologies. The potential to revolutionize patient care and outcomes is immense, and generative AI is at the forefront of this exciting journey in healthcare. #GenerativeAI #DrugDiscovery #PharmaceuticalInnovation #HealthcareTechnology

𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗔𝗜 𝗶𝗻 𝘁𝗵𝗲 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 & 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆: 𝗔 𝗚𝗮𝗺𝗲 𝗖𝗵𝗮𝗻𝗴𝗲𝗿 🚀 The pharmaceutical & Medical Device industry has always been subject to change, and in recent years, we’ve witnessed a rapid evolution driven by emerging trends and innovative technologies. As professionals in these industries, it's imperative that we adapt our mindset and skills to navigate through these changes and embracing these advancements to enhance patient safety, product quality, regulatory compliance, and operational efficiency. 𝗝𝗼𝗶𝗻 𝗮𝘀 𝗮𝘁 𝘁𝗵𝗲 𝘂𝗽𝗰𝗼𝗺𝗶𝗻𝗴 IFF - Industrielt Farma & medico Forum 𝗲𝘃𝗲𝗻𝘁 🤝 The 23rd of May, Naram El-Shamary, our Co-founder & Partner at ImproveMatic, will delve into the transformative trends and innovations shaping these industries, with a particular focus on artificial intelligence (AI) and data analytics within life science. Our session will provide an overall understanding of AI and digital solutions, explore the opportunities AI offers, present some AI examples, and address the key factors for AI from a Quality & Compliance perspective. Additionally, we will discuss the benefits and challenges associated with incorporation of AI into Pharmaceutical & Medical processes. A big thanks to IFF for extending the invitation to shed light on AI from a Quality & Compliance perspective. We are thrilled to be part of this session. See you there! 👏🏼 Sign up for the session here: https://lnkd.in/eMtnsGc #ImproveMatic #AI #QualityandCompliance